In this episode, faculty review MIGS cases: an older patient that could no longer be compliance with drops and a pseudophakic glaucoma patient whose disease is progressing.
This course features bonus case material. View it here
Supported by an unrestricted educational grant from Sight Sciences.
1. Compare and contrast standalone and cataract MIGS (minimally invasive glaucoma surgery) patients: Patient demographics, surgical procedure, and patient follow-up parameters
2. Understand the MIGS patient journey: How to identify ideal MIGS patients, educate and set expectations, and manage these patients postop
There is no credit associated with this course.
Christopher May, OD
Coldwater Vision Center
Justin Schweitzer, OD
Vance Thompson Vision
Sioux Falls, SD
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Kristopher May, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, and Sight Sciences. Speaker’s Bureau: Alcon, Bausch + Lomb, and Sight Sciences.
Justin Schweitzer, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Dompe, EyePoint, Horizon, Ocular Therapeutix, and Reichert. Grant/Research Support: Glaukos. Speaker’s Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Glaukos, Quidel, Sight Sciences, and Sun Pharmaceuticals. Share/Stockholder: Equinox.
The Evolve Medical Education or The Fundingsland Group staff and planners have no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group or Sight Sciences.
By: Dr. May and Dr. Schweitzer